GenesisCare

OverviewSuggest Edit

GenesisCare is a leading healthcare provider. It specializes in the treatment of cancer, heart disease, sleep, and respiratory conditions.
TypePrivate
Founded2009
Websitegenesiscare.com

Latest Updates

Employees (est.) (Feb 2020)2,500
Cybersecurity ratingAMore

Key People/Management at GenesisCare

Dan Collins

Dan Collins

Founder, CEO & Director
Michael Guiney

Michael Guiney

Oncologist Director, GenesisCare
David O'Donnell

David O'Donnell

Cardiologist Director
Simon McGrath

Simon McGrath

Independent Director
Kerry Zhang

Kerry Zhang

Investor Director
Bruce Wang

Bruce Wang

Investor Director
Show more

GenesisCare Office Locations

GenesisCare has offices in Alexandria, Madrid and Windsor
Alexandria, AU
Building 11 The Mill, 41-43 Bourke Rd
Madrid, ES
Calle de Emilio Vargas, 16
Windsor, GB
69 Alma Rd
Show all (3)

GenesisCare Financials and Metrics

Summary Metrics

Founding Date

2009

GenesisCare total Funding

$937.3 m

GenesisCare latest funding size

$900 m

Time since last funding

2 years ago

GenesisCare investors

GenesisCare's latest funding round in October 2018 was reported to be $900 m. In total, GenesisCare has raised $937.3 m
Show all financial metrics

GenesisCare Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

GenesisCare Online and Social Media Presence

Embed Graph

GenesisCare Frequently Asked Questions

  • When was GenesisCare founded?

    GenesisCare was founded in 2009.

  • Who are GenesisCare key executives?

    GenesisCare's key executives are Dan Collins, Michael Guiney and David O'Donnell.

  • How many employees does GenesisCare have?

    GenesisCare has 2,500 employees.

  • Who are GenesisCare competitors?

    Competitors of GenesisCare include Lexent Bio, St. Jude Children's Research Hospital and Outlook Therapeutics.

  • Where are GenesisCare offices?

    GenesisCare has offices in Alexandria, Madrid and Windsor.

  • How many offices does GenesisCare have?

    GenesisCare has 3 offices.